About

Pietro Riva is a leading researcher in surgical innovation, with a primary focus on cost-effectiveness and skill acquisition in minimally invasive pancreatic surgery. His landmark 2018 study, cited 49 times, rigorously compared the clinical and economic outcomes of open, laparoscopic, and robotic distal pancreatectomy, providing critical evidence that robotic surgery can be cost-effective for benign and malignant diseases. This work has shaped institutional protocols by demonstrating that advanced technology can deliver comparable or superior outcomes without prohibitive costs. More recently, Riva’s 2023 prospective observational study on minimally invasive surgery skill acquisition across novice levels offers foundational insights into training pathways, addressing a key gap in surgical education. By quantifying how surgeons progress from basic to advanced techniques, his research directly informs curriculum design and patient safety standards. With a growing citation impact, Riva’s contributions bridge health economics, surgical oncology, and education, making him a pivotal voice in the evolution of pancreatic surgery. His work empowers surgeons and policymakers to adopt cost-conscious, evidence-based approaches that improve patient outcomes and training efficiency.

Research Focus

Key Achievements

2
H-Index
2
Papers
51
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Which method of distal pancreatectomy is cost-effective among open, laparoscopic, or robotic surgery?
49 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Hôpitaux Universitaires de Strasbourg, Institut de Recherche contre les Cancers de l’Appareil Digestif

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago